The influences of NO and Ach on cGMP levels in two patient populations

Journal of Extra-Corporeal Technology

Volumn 33, Issue 1, 2001, Pages 23-26

  Jiang, Z ^a   Lei, Y ^a   Gu, K ^a   Xianghua, J ^a   Liming, X ^a   Kejian, H ^a  

^a Shanghai Institute of Cardiovascular Diseases   (China)

Author keywords

Acetylcholine cGMP; Cardiopulmonary bypass; NO

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; NITRIC OXIDE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM INJURY; FEMALE; HEART VALVE SURGERY; HUMAN; INJECTION; LUNG ARTERY PRESSURE; MALE; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; STERNOTOMY; SURGICAL MORTALITY; VASCULAR ENDOTHELIUM;

EID: 0035099939     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Endothelial dysfunction in pulmonary hypertension
2. Venoarterial extracorporeal membrane oxygenation - How safe is it?
3. Diagnosis and management of postoperative pulmonary hypertensive crisis
4. Nitric oxide regular basal systemic and pulmonary vascular resistance in healthy humans
5. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: Stimulation by acetylcholine, bryadykinin and arachidonic acid
6. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart diseases
7. Role of EDRF during transition of pulmonary circulation at birth
8. Control of coronary vascular tone by nitric oxide
9. Regulatory function of vascular endothelium
10. Oxygen radical mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries